With Genomic Health’s online physician portal, ordering a test is easy, tracking test progress, and accessing results are convenient and efficient. On the portal:
Order with Ease
Confidence in management decisions for your patients
- Orders can be submitted online—virtually eliminating the need for follow-up calls to complete any missing information.
- All patient orders and results reports can be viewed, tracked, and sorted quickly.
- Orders and results reports may be viewed online, printed, or downloaded as PDFs.
If you have do not have an online portal account, sign up now for a new account. If you have forgotten your user ID or password, reset it on the account activation form.
Contact Customer Service at ( 866-ONCOTYPE866-662-6897) or by email at firstname.lastname@example.org if you have questions about the process.
Step-by-step instructions for patients in the United States
Ordering an Oncotype DX test and receiving the results is a straightforward process. Simply follow these 4 steps.
STEP 1 of 4
Get specimen kits
Genomic Health provides a specimen transportation kit box for each patient’s tissue sample. To request specimen transportation kit boxes contact the Customer Service team at ( 866-ONCOTYPE866-662-6897).
Kit orders are usually processed within a day and received within 48 hours.
STEP 2 of 4
Complete requisition form
Please fill out each section of the requisition form completely. It's most efficient to complete your requisition form online. Simply login to the online physician portal or order more efficiently by signing up for an online portal account.
Download an example of a paper requisition form (PDF) including instructions for more details.
STEP 3 of 4
Submit a sample
Genomic Health can work directly with the pathology team (or the treating physician) to obtain a sample.
When submitting an invasive tumor sample for the Oncotype DX Breast Recurrence Score test please choose the block with both the greatest amount (cross-sectional area) of highest grade invasive breast carcinoma and when possible, the least amount of non-invasive mammary epithelium (in situ carcinoma, hyperplastic epithelium, normal epithelium). While the Genomic Health laboratory can accept tumor blocks and unstained slides, blocks are preferred due to the frequent requirement for manual macrodissection of the specimen consistent with clinical trial experience. In rare cases, the diagnostic needle core biopsy may be the optimal sample for testing than the excisional sample; if this is the case, then the needle core biopsy should be submitted.
All specimens must be labeled with S barcode labels from the Oncotype DX specimen collection and transportation kit box for that patient.
Download the pathology guidelines (PDF) for more information.
STEP 4 of 4
Most Recurrence Score results are available within two weeks from the date we receive your patient’s sample in our laboratory. You can access the results through the online physician portal or receive the report by fax. Learn more about the results report and how to interpret the results.